INFUSYSTEM HOLDINGS, INC. Financials InfuSystem Holdings, Inc.
Equities
INFU
US45685K1025
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.12 USD | +6.70% |
|
-0.98% | -22.96% |
| Apr. 10 | Gregg Lehman Not to Stand for Re-Election as Director of InfuSystem Holdings, Inc | CI |
| Mar. 14 | Transcript : InfuSystem Holdings, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 169.3 | 380 | 351.7 | 179.3 | 223.3 | 172.7 | - |
| Enterprise Value (EV) 1 | 169.3 | 380 | 351.7 | 179.3 | 223.3 | 172.7 | 172.7 |
| P/E ratio | 122 x | 23.5 x | 284 x | - | 264 x | 52.4 x | 19.3 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 2.09 x | 3.9 x | 3.43 x | 1.63 x | 1.78 x | 1.27 x | 1.17 x |
| EV / Revenue | 2.09 x | 3.9 x | 3.43 x | 1.63 x | 1.78 x | 1.27 x | 1.17 x |
| EV / EBITDA | - | 16.7 x | 14.6 x | 8.64 x | 9.98 x | 6.77 x | - |
| EV / FCF | - | 113 x | 212 x | 73.5 x | - | 43.4 x | 18.9 x |
| FCF Yield | - | 0.89% | 0.47% | 1.36% | - | 2.3% | 5.29% |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 19,843 | 20,237 | 20,649 | 20,656 | 21,184 | 21,265 | - |
| Reference price 2 | 8.530 | 18.78 | 17.03 | 8.680 | 10.54 | 8.120 | 8.120 |
| Announcement Date | 3/19/20 | 3/17/21 | 2/10/22 | 3/15/23 | 3/14/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 81.12 | 97.39 | 102.4 | 109.9 | 125.8 | 135.4 | 148 |
| EBITDA 1 | - | 22.82 | 24.05 | 20.74 | 22.37 | 25.5 | - |
| EBIT 1 | - | 9.615 | 2.82 | 1.654 | 4.088 | 6.058 | 12.1 |
| Operating Margin | - | 9.87% | 2.75% | 1.5% | 3.25% | 4.47% | 8.17% |
| Earnings before Tax (EBT) 1 | - | 7.543 | 1.257 | 0.13 | 1.851 | 4.358 | 12.3 |
| Net income 1 | - | 17.33 | 1.42 | 0.018 | 0.872 | 3.318 | 9.223 |
| Net margin | - | 17.8% | 1.39% | 0.02% | 0.69% | 2.45% | 6.23% |
| EPS 2 | 0.0700 | 0.8000 | 0.0600 | - | 0.0400 | 0.1550 | 0.4200 |
| Free Cash Flow 1 | - | 3.366 | 1.66 | 2.441 | - | 3.98 | 9.138 |
| FCF margin | - | 3.46% | 1.62% | 2.22% | - | 2.94% | 6.17% |
| FCF Conversion (EBITDA) | - | 14.75% | 6.9% | 11.77% | - | 15.61% | - |
| FCF Conversion (Net income) | - | 19.42% | 116.9% | 13,561.11% | - | 119.95% | 99.08% |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 3/19/20 | 3/17/21 | 2/10/22 | 3/15/23 | 3/14/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 26.57 | 26.52 | 26.76 | 27.04 | 27.28 | 28.83 | 30.37 | 31.74 | 31.91 | 31.77 | 31.55 | 33.55 | 34.25 | 36.15 | 33.5 |
| EBITDA 1 | 5.495 | 6.515 | 4.142 | 5.526 | 5.604 | 5.473 | 4.235 | 5.761 | 6.217 | 6.153 | 5.4 | 6.1 | 6.7 | 7.3 | - |
| EBIT 1 | -0.351 | 1.602 | -0.525 | 0.207 | 0.943 | 1.029 | -0.107 | 1.248 | 1.697 | 1.25 | 0.6075 | 1.205 | 1.715 | 2.48 | 1.488 |
| Operating Margin | -1.32% | 6.04% | -1.96% | 0.77% | 3.46% | 3.57% | -0.35% | 3.93% | 5.32% | 3.93% | 1.93% | 3.59% | 5.01% | 6.86% | 4.44% |
| Earnings before Tax (EBT) 1 | -0.665 | 1.098 | -0.83 | -0.137 | 0.547 | 0.55 | -0.626 | 0.63 | 1.12 | 0.727 | 0.1575 | 0.805 | 1.365 | 1.98 | 1.488 |
| Net income 1 | -0.448 | 0.387 | -0.368 | -0.164 | 0.443 | 0.107 | -0.324 | 0.435 | 0.689 | 0.072 | 0.1305 | 0.604 | 1.036 | 1.498 | 1.116 |
| Net margin | -1.69% | 1.46% | -1.38% | -0.61% | 1.62% | 0.37% | -1.07% | 1.37% | 2.16% | 0.23% | 0.41% | 1.8% | 3.03% | 4.14% | 3.33% |
| EPS 2 | -0.0200 | 0.0200 | -0.0200 | -0.0100 | 0.0200 | 0.0100 | -0.0200 | 0.0200 | 0.0300 | - | 0.005000 | 0.0300 | 0.0500 | 0.0700 | 0.0500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/15/21 | 2/10/22 | 5/5/22 | 8/4/22 | 11/8/22 | 3/15/23 | 5/4/23 | 8/3/23 | 11/7/23 | 3/14/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 3.37 | 1.66 | 2.44 | - | 3.98 | 9.14 |
| ROE (net income / shareholders' equity) | - | 54.9% | 3.19% | 0.04% | - | 5.4% | 12.7% |
| ROA (Net income/ Total Assets) | - | 19.7% | 1.46% | 0.02% | - | 2.9% | 7.3% |
| Assets 1 | - | 88.11 | 97.29 | 98.52 | - | 114.4 | 126.3 |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | - | 1.09 | 0.98 | 0.98 | - | 0.5 | 0.5 |
| Capex / Sales | - | 1.12% | 0.96% | 0.89% | - | 0.37% | 0.34% |
| Announcement Date | 3/19/20 | 3/17/21 | 2/10/22 | 3/15/23 | 3/14/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
8.12
USD
Average target price
14.75
USD
Spread / Average Target
+81.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.96% | 173M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- INFU Stock
- Financials InfuSystem Holdings, Inc.
